메뉴 건너뛰기




Volumn 22, Issue 3, 2009, Pages 151-172

Recommendations in the empiric anti-infective agents of intra-abdominal infection;Recomendaciones en el tratamiento antibiótico empírico de la infección intraabdominal

Author keywords

Anti infective agents; Guidelines; Intra abdominal infection

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; ANIDULAFUNGIN; AZTREONAM; BETA LACTAMASE INHIBITOR; C REACTIVE PROTEIN; CARBAPENEM DERIVATIVE; CASPOFUNGIN; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; COLISTIN; DAPTOMYCIN; ERTAPENEM; FLUCONAZOLE; GENTAMICIN; IMIPENEM; LACTIC ACID; LINEZOLID; MEROPENEM; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; PROCALCITONIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TIGECYCLINE; UNINDEXED DRUG; ANTIINFECTIVE AGENT;

EID: 74249110630     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (36)

References (115)
  • 1
    • 16244402349 scopus 로고    scopus 로고
    • Longitudinal outcomes of intraabdominal infection complicated by critical illness
    • Barie P, Hydo L, Eachempati S. Longitudinal outcomes of intraabdominal infection complicated by critical illness. Surg Infect 2004;5:365-73.
    • (2004) Surg Infect , vol.5 , pp. 365-373
    • Barie, P.1    Hydo, L.2    Eachempati, S.3
  • 2
    • 57749107808 scopus 로고    scopus 로고
    • Bad bugs, no drugs: No ESKAPE! An update from the infectious diseases society of America
    • Boucher H, Talbot G, Bradley J, Edwards J, Gilbert D, Rice L et al. Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America. Clin Infect Dis 2009;48:1-12.
    • (2009) Clin Infect Dis , vol.48 , pp. 1-12
    • Boucher, H.1    Talbot, G.2    Bradley, J.3    Edwards, J.4    Gilbert, D.5    Rice, L.6
  • 4
    • 36349026958 scopus 로고    scopus 로고
    • Consequences of inappropriate initial empiric parenteral antibiotic therapy among patients with community-acquired intra-abdominal infections in Spain
    • Tellado J, Sen S, Caloto M, Kumar R, Nocea G. Consequences of inappropriate initial empiric parenteral antibiotic therapy among patients with community-acquired intra-abdominal infections in Spain. Scand J Infect Dis 2007;39:947-55.
    • (2007) Scand J Infect Dis , vol.39 , pp. 947-955
    • Tellado, J.1    Sen, S.2    Caloto, M.3    Kumar, R.4    Nocea, G.5
  • 5
    • 77956481167 scopus 로고    scopus 로고
    • Estudio de adecuación de la antibioticoterapia empírica en el tratamiento de la infección intraabdominal complicada
    • Madrid 3-6 de noviembre del 2008
    • Sitges-Serra A, Sancho-Isenser J, Membrilla E, Girvent M y Grupo de estudio PEPES (Patógenos emergentes en peritonitis). Estudio de adecuación de la antibioticoterapia empírica en el tratamiento de la infección intraabdominal complicada. XXVII Congreso Nacional de Cirugía. Madrid 3-6 de noviembre del 2008.
    • XXVII Congreso Nacional de Cirugía
    • Sitges-Serra, A.1    Sancho-Isenser, J.2    Membrilla, E.3    Girvent, M.4
  • 6
    • 0029833749 scopus 로고    scopus 로고
    • Emergence of antibiotic-resistant bacteria in cases of peritonitis after inbtraabdominal surgery affects the efficacy of empirical antimicrobial therapy
    • Montravers P, Gauzit R, Muller C, Marmuse J, Fichelle A, Desmonts J. Emergence of antibiotic-resistant bacteria in cases of peritonitis after inbtraabdominal surgery affects the efficacy of empirical antimicrobial therapy. Clin Infect Dis 1996;23:486-94.
    • (1996) Clin Infect Dis , vol.23 , pp. 486-494
    • Montravers, P.1    Gauzit, R.2    Muller, C.3    Marmuse, J.4    Fichelle, A.5    Desmonts, J.6
  • 8
    • 33144458256 scopus 로고    scopus 로고
    • In vitro susceptibilities of aerobic and facultative Grameegative bacilli isolated from patients with intra- abdominal infections worldwide: The 2002 Study for Monitoring Antimicrobial Resistance Trends (SMART)
    • Chow J, Satishchandran V, Snyder T, Harvey C, Friedland I, Dinubile M. In vitro susceptibilities of aerobic and facultative Grameegative bacilli isolated from patients with intra- abdominal infections worldwide: The 2002 Study for Monitoring Antimicrobial Resistance Trends (SMART). Surg Infect 2006;6:439-47.
    • (2006) Surg Infect , vol.6 , pp. 439-447
    • Chow, J.1    Satishchandran, V.2    Snyder, T.3    Harvey, C.4    Friedland, I.5    Dinubile, M.6
  • 10
    • 33748044288 scopus 로고    scopus 로고
    • In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends)
    • DOI 10.1093/jac/dkl199
    • Rossi F, Baquero F, Hsuech P, Paterson D, Bochicchio G, Snyder T et al. In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). J Antimicrob Chemother 2006;58:205-10. (Pubitemid 44295010)
    • (2006) Journal of Antimicrobial Chemotherapy , vol.58 , Issue.1 , pp. 205-210
    • Rossi, F.1    Baquero, F.2    Hsueh, P.-R.3    Paterson, D.L.4    Bochicchio, G.V.5    Snyder, T.A.6    Satishchandran, V.7    McCarroll, K.8    DiNubile, M.J.9    Chow, J.W.10
  • 11
    • 62549100893 scopus 로고    scopus 로고
    • Clinical and microbiolocal profiles and community-acquired and nosocomial intra-abdominal infections: Reults of the French prospective, observational EBIIA study
    • Montravers P, Lepape A, Dubreuil L, Gauzit R, Pean, Y, Benchimol D et al. Clinical and microbiolocal profiles and community-acquired and nosocomial intra-abdominal infections:reults of the French prospective, observational EBIIA study. J Antimicrob Chemother 2009;63:785-94.
    • (2009) J Antimicrob Chemother , vol.63 , pp. 785-794
    • Montravers, P.1    Lepape, A.2    Dubreuil, L.3    Gauzit, R.4    Pean, Y.5    Benchimol, D.6
  • 12
    • 0035829842 scopus 로고    scopus 로고
    • Early goal-directed therapy in the treatment of severe sepsis and septic shock
    • Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368-77.
    • (2001) N Engl J Med , vol.345 , pp. 1368-1377
    • Rivers, E.1    Nguyen, B.2    Havstad, S.3    Ressler, J.4    Muzzin, A.5    Al Et, K.B.6
  • 13
    • 33744527833 scopus 로고    scopus 로고
    • Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock
    • Kumar A, Roberts D, Wood K, Light B, Parrillo J, Sharma S et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006;34:1589-96.
    • (2006) Crit Care Med , vol.34 , pp. 1589-1596
    • Kumar, A.1    Roberts, D.2    Wood, K.3    Light, B.4    Parrillo, J.5    Et Al., S.S.6
  • 14
    • 0022256529 scopus 로고
    • APACHE II: A severity of disease classification system
    • Knaus W, Draper E, Wagner D, Zimmerman J. APACHE II: A severity of disease classification system. Crit Care Med 1985;13:818-29.
    • (1985) Crit Care Med , vol.13 , pp. 818-829
    • Knaus, W.1    Draper, E.2    Wagner, D.3    Zimmerman, J.4
  • 15
    • 0030015661 scopus 로고    scopus 로고
    • The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. on behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care of Medicine
    • Vincent J, Moreno R, Takala J, Willats S, De Mendonça A, Bruining H et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care of Medicine. Intensive Care Med 1996;22:707-10.
    • (1996) Intensive Care Med , vol.22 , pp. 707-710
    • Vincent, J.M.1
  • 16
    • 0026874127 scopus 로고
    • American College of Chest Physicians/society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
    • Members of the American College of Chest Pysicians
    • Members of the American College of Chest Pysicians. American College of Chest Physicians/society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-74.
    • (1992) Crit Care Med , vol.20 , pp. 864-874
  • 18
    • 79551511373 scopus 로고    scopus 로고
    • Monitorización de la proteína C-reactiva en el diagnóstico precoz de las complicaciones mayores en la cirugía colo-rectal electiva
    • Madrid
    • Guirao X, Franch G, Navinés J, Casal M, Juvany M, Montero J et al. Monitorización de la proteína C-reactiva en el diagnóstico precoz de las complicaciones mayores en la cirugía colo-rectal electiva. In: XXVII Congreso Nacional de Cirugía, Madrid; 2008.
    • (2008) XXVII Congreso Nacional de Cirugía
    • Guirao, X.F.1
  • 19
    • 67650489580 scopus 로고    scopus 로고
    • Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock
    • Mikkelsen M, Miltiades A, Gaieski D, Goyal M, Fuchs B, Shah C et al. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit Care Med 2009;37:1670-777.
    • (2009) Crit Care Med , vol.37 , pp. 1670-1777
    • Mikkelsen, M.1    Miltiades, A.2    Gaieski, D.3    Goyal, M.4    Fuchs, B.5    Et Al., S.C.6
  • 21
    • 34249809121 scopus 로고    scopus 로고
    • C-reactive Protein enhances immunity to strptococcus pneumoniae by targeting uptke to FcgR on dentritic cells
    • Thomas-Rudolph D, Du clos T, Snapper C, Mold C. C-reactive Protein enhances immunity to strptococcus pneumoniae by targeting uptke to FcgR on dentritic cells. J Immunol 2007;178:7283-91.
    • (2007) J Immunol , vol.178 , pp. 7283-7291
    • Thomas-Rudolph, D.1    Du Clos, T.2    Snapper, C.3    Mold, C.4
  • 22
    • 11144281879 scopus 로고    scopus 로고
    • C-reactive protein used as an early indicator of infection in patients with systemic inflammatory syndrome
    • Sierra R, Rello J, Bailen M, Benítez E, Gordillo A, León C et al. C-reactive protein used as an early indicator of infection in patients with systemic inflammatory syndrome. Intensive Care Med 2004;30:2038-45.
    • (2004) Intensive Care Med , vol.30 , pp. 2038-2045
    • Sierra, R.R.1
  • 23
    • 0036191395 scopus 로고    scopus 로고
    • Diagnosis and follow-up of infections in intensive care patients: Value of C-reactive protein compared with other clinical and biological varIIAles
    • Reny J, Vuagnat A, Ract A, M B, Safar M, Fagon J. Diagnosis and follow-up of infections in intensive care patients: value of C-reactive protein compared with other clinical and biological varIIAles. Crit Care Med 2002;30:529-35.
    • (2002) Crit Care Med , vol.30 , pp. 529-535
    • Reny, J.1    Vuagnat, A.2    Ract, A.3    M, B.4    Safar, M.5    Fagon, J.6
  • 24
    • 45849104786 scopus 로고    scopus 로고
    • The time course of blood c-reactive protein concentrations in relation to the response to initial antimicrobial therapy in patients with sepsis
    • Schmit X, Vincent J. The Time Course of Blood C-reactive Protein concentrations in relation to the response to initial antimicrobial therapy in patients with sepsis. Infection 2008;36:213-9.
    • (2008) Infection , vol.36 , pp. 213-219
    • Schmit, X.1    Vincent, J.2
  • 25
  • 26
    • 57149120295 scopus 로고    scopus 로고
    • Procalcitonin ratio indicates successful surgical treatment of abdominal sepsis
    • Novotny A, Emmanuel K, Hueser N, Knebel C, Kriner M, Ulm K et al. Procalcitonin ratio indicates successful surgical treatment of abdominal sepsis. Surgery 2009;145:20-6.
    • (2009) Surgery , vol.145 , pp. 20-26
    • Novotny, A.1    Emmanuel, K.2    Hueser, N.3    Knebel, C.4    Kriner, M.5    Et Al., U.K.6
  • 27
    • 33847127517 scopus 로고    scopus 로고
    • Evaluation of procalcitonin for predicting septic multiorgan failure and overall prognosis in secondary peritonitis
    • Rau B, Frigerio I, Büchler M, Wegscheider K, Bassi C, Puolakkainen P et al. Evaluation of procalcitonin for predicting septic multiorgan failure and overall prognosis in secondary peritonitis. Arch Surg 2007;142:134-42.
    • (2007) Arch Surg , vol.142 , pp. 134-142
    • Rau, B.F.1
  • 28
    • 33847056146 scopus 로고    scopus 로고
    • Accuracy of procalcitonin for sepsis diagnosis in critically ill patients:systematic review and meta-analysis
    • Tang B, Eslick G, Craig J, McLean A. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients:systematic review and meta-analysis. Lancet Infect Dis 2007;7:210-7.
    • (2007) Lancet Infect Dis , vol.7 , pp. 210-217
    • Tang, B.1    Eslick, G.2    Craig, J.3    McLean, A.4
  • 29
    • 9344239309 scopus 로고    scopus 로고
    • Modification of empiric antibiotic treatment in patients with penumonia acquired in the intensive care unit. ICY-Acquired Pneumonia Study Group
    • Álvarez-Lerma F. Modification of empiric antibiotic treatment in patients with penumonia acquired in the intensive care unit. ICY-Acquired Pneumonia Study Group. Intensive Care Med 1996;22:387-94.
    • (1996) Intensive Care Med , vol.22 , pp. 387-394
    • Álvarez-Lerma, F.1
  • 30
    • 0032911760 scopus 로고    scopus 로고
    • Inadequate antimicrobial treatment of nfections: A risk factor for hospital mortality among critically ill patients
    • Kollef M, Sherman G, Ward S, Fraser V. Inadequate antimicrobial treatment of nfections: A risk factor for hospital mortality among critically ill patients. Chest 1999;115:462-74.
    • (1999) Chest , vol.115 , pp. 462-474
    • Kollef, M.1    Sherman, G.2    Ward, S.3    Fraser, V.4
  • 32
    • 0141610906 scopus 로고    scopus 로고
    • The influence of inadequate antimicrobial treatment of bloodstream infections on patients outcomes in the ICU setting
    • Ibrahim E, Sherman G, Ward S, Frase V, Kollef M. The influence of inadequate antimicrobial treatment of bloodstream infections on patients outcomes in the ICU setting. Chest 2000;118:146.
    • (2000) Chest , vol.118 , pp. 146
    • Ibrahim, E.1    Sherman, G.2    Ward, S.3    Frase, V.4    Kollef, M.5
  • 33
    • 4644296739 scopus 로고    scopus 로고
    • Effect of inappropiate initial empiric antibiotic therapy on outcome of patients with community-acquiered intra-abdominal infections requiring surgery
    • Krobot K, Yin D, Zhang Q, Sen S, Altendorf-Hofmann A, Scheele J et al. Effect of inappropiate initial empiric antibiotic therapy on outcome of patients with community-acquiered intra-abdominal infections requiring surgery. Eur J Clin Microbiol Infec Dis 2004;23:682-7.
    • (2004) Eur J Clin Microbiol Infec Dis , vol.23 , pp. 682-687
    • Krobot, K.1    Yin, D.2    Zhang, Q.3    Sen, S.4    Altendorf-Hofmann, A.5    Et Al., S.J.6
  • 34
    • 33645759039 scopus 로고    scopus 로고
    • Importance of apopropiateness of empiric antibiotic therapy on clinical outcomes in intra-abdominal infections
    • Bare M, Castells X, Garcia A, Riu M, Comas M, Gil-Egea M. Importance of apopropiateness of empiric antibiotic therapy on clinical outcomes in intra-abdominal infections. Int J Technol Assess Healt Care 2006;22:242-8.
    • (2006) Int J Technol Assess Healt Care , vol.22 , pp. 242-248
    • Bare, M.1    Castells, X.2    Garcia, A.3    Riu, M.4    Comas, M.5    Gil-Egea, M.6
  • 35
    • 0037170578 scopus 로고    scopus 로고
    • Rapid antibiotic delivery and appropiate antibiotic selection reduce llenght of hospital stay of patients with community-acquired pneumonia
    • Battelmen D, Callahan M, Thaler H. Rapid antibiotic delivery and appropiate antibiotic selection reduce llenght of hospital stay of patients with community-acquired pneumonia. Arch Intern Med 2002;162:682-8.
    • (2002) Arch Intern Med , vol.162 , pp. 682-688
    • Battelmen, D.1    Callahan, M.2    Thaler, H.3
  • 36
    • 26444601973 scopus 로고    scopus 로고
    • Inappropiate initial treatment of secondary intra-abdomial infections leads to increased risk of clinical failure and costs
    • Sturkenboom M, Goettsch W, Picelli G, Veld B, Yin D, de Jong R et al. Inappropiate initial treatment of secondary intra-abdomial infections leads to increased risk of clinical failure and costs. Br J Clin Pharmacol 2005;60:438-43.
    • (2005) Br J Clin Pharmacol , vol.60 , pp. 438-443
    • Sturkenboom, M.1    Goettsch, W.2    Picelli, G.3    Veld, B.4    Yin, D.5    De Jong, R.6
  • 37
    • 0033915639 scopus 로고    scopus 로고
    • Monotherapy with a broad-spectrum beta-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalizaed peritonitis: A multicenter randomized controlled trial
    • Dupont H, Carbon C, Carlet J, Severe Generalized Perintonits Study Group T. Monotherapy with a broad-spectrum beta-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalizaed peritonitis: a multicenter randomized controlled trial. Antimicrob Ag Chemother 2000;44:2028-33.
    • (2000) Antimicrob Ag Chemother , vol.44 , pp. 2028-2033
    • Dupont, H.1    Carbon, C.2    Et Al., C.J.3
  • 38
    • 0030776838 scopus 로고    scopus 로고
    • Abdominal operation in patients with cirrhosis: Still a major surgical challange
    • Mansour A, Watson W, Shayani V, Pickelman J. Abdominal operation in patients with cirrhosis: Still a major surgical challange. Surgery 1997;122:730-5.
    • (1997) Surgery , vol.122 , pp. 730-735
    • Mansour, A.1    Watson, W.2    Shayani, V.3    Pickelman, J.4
  • 39
    • 0030471240 scopus 로고    scopus 로고
    • Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections
    • Falagas M, Barefoot L, Griffith J, Ruthzar R, Snydman D. Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections. Eur J Clin Microbiol Infec Dis 1996;1512:913-21.
    • (1996) Eur J Clin Microbiol Infec Dis , vol.1512 , pp. 913-921
    • Falagas, M.1    Barefoot, L.2    Griffith, J.3    Ruthzar, R.4    Snydman, D.5
  • 41
    • 0036122122 scopus 로고    scopus 로고
    • Postoperative enterococcal infection after treatment of complicated intra-abdominal sepsis
    • Sitges-Serra A, Lopez M, Girvent M, Almirall S, Sancho J. Postoperative enterococcal infection after treatment of complicated intra-abdominal sepsis. Br J Surg 2002;89:361-7.
    • (2002) Br J Surg , vol.89 , pp. 361-367
    • Sitges-Serra, A.1    Lopez, M.2    Girvent, M.3    Almirall, S.4    Sancho, J.5
  • 42
    • 77956454458 scopus 로고    scopus 로고
    • Infecciones por bacterias productoras de |β-lacta- masas
    • Guirao X, Diaz JA, editores, Madrid: Arán Editores
    • Gobernado M. Infecciones por bacterias productoras de |β-lacta- masas. En: Guirao X, Diaz JA, editores. Infecciones Quirúrgicas. Madrid: Arán Editores, 2006; p. 483-486.
    • (2006) Infecciones Quirúrgicas , pp. 483-486
    • Gobernado, M.1
  • 43
    • 61449170007 scopus 로고    scopus 로고
    • In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2005. Results from study for monitoring antimicrobial resistance trends (SMART)
    • Baquero F, Hsuech P, Paterson D, Rossi F, Biochicchio G, Gallagher G et al. In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2005. Results from study for monitoring antimicrobial resistance trends (SMART). Surg Infect 2008.
    • (2008) Surg Infect
    • Baquero, F.1    Hsuech, P.2    Paterson, D.3    Rossi, F.4    Biochicchio, G.5    Et Al., G.G.6
  • 44
    • 85018193526 scopus 로고    scopus 로고
    • Increasing prevalence of ESBL-producing enterobacteriacea in Europe
    • Coque T, Baquero F, Cantón R. Increasing prevalence of ESBL-producing enterobacteriacea in Europe. Eurosurveillance 2008;13:1-11.
    • (2008) Eurosurveillance , vol.13 , pp. 1-11
    • Coque, T.1    Baquero, F.2    Cantón, R.3
  • 45
    • 33744755662 scopus 로고    scopus 로고
    • Patrones de sensiblidad a antimicrobianos en enterobacterias causantes de infecciones intraabdominales en España: resultados del estudio SMART 2003
    • Baquero F, Cecenado E, Cisterna R, de la Rosa M, García-Rodriguez J, Gobernado M et al. Patrones de sensiblidad a antimicrobianos en enterobacterias causantes de infecciones intraabdominales en España: resultados del estudio SMART 2003. Rev Esp Quimioter 2006;19:51-9.
    • (2006) Rev Esp Quimioter , vol.19 , pp. 51-59
    • Baquero F, C.1
  • 46
    • 33645062398 scopus 로고    scopus 로고
    • A Change in the epidemiology of infections due to extended-spectrum b-lactamase-producing organisms
    • Rodríguez-Baño J, Paterson D. A Change in the epidemiology of infections due to extended-spectrum b-lactamase-producing organisms. Clin Infect Dis 2006;42:935-7.
    • (2006) Clin Infect Dis , vol.42 , pp. 935-937
    • Rodríguez-Baño Paterson, J.D.1
  • 47
    • 37249052710 scopus 로고    scopus 로고
    • Prevalence and spread of extended-spectrum b-lactamaseproducing enterobacteriaceae in Europe
    • Cantón R, Novais A, Valverde A, Mchado E, Peixe L, Baquero F et al. Prevalence and spread of extended-spectrum b-lactamaseproducing enterobacteriaceae in Europe. Clin Microbiol Infect 2008;14(Supl. 1):144-53.
    • (2008) Clin Microbiol Infect , vol.14 , Issue.SUPPL. 1 , pp. 144-53
    • Cantón, R.N.1
  • 48
    • 60149108086 scopus 로고    scopus 로고
    • Impacto de las BLEE en los tratamientos empíricos y las políticas antibióticas
    • Rodríguez-Baño J, Navarro M. Impacto de las BLEE en los tratamientos empíricos y las políticas antibióticas. Enferm Infecc Microbiol Clin 2007;25 (Supl. 2):54-9.
    • (2007) Enferm Infecc Microbiol Clin , vol.25 , Issue.SUPPL. 2 , pp. 54-59
    • Rodríguez-Baño Navarro, J.M.1
  • 49
    • 22144436291 scopus 로고    scopus 로고
    • Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City. A new threat to our antibiotic armamentarium
    • Bratu S, Landman D, Haag R, Recco R, Eramo A, Alam M et al. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City. A new threat to our antibiotic armamentarium. Arch Intern Med 2005;165:1430-5.
    • (2005) Arch Intern Med , vol.165 , pp. 1430-1435
    • Bratu, S.1    Landman, D.2    Haag, R.3    Recco, R.4    Eramo, A.5    Et Al., A.M.6
  • 50
    • 43549125211 scopus 로고    scopus 로고
    • Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss
    • Gülmez D, Woodford N, Pelepou M, Musthaq S, Metan G, Yakupogullari Y et al. Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss. Int J Antimicrob Ag 2008;31:523-6.
    • (2008) Int J Antimicrob Ag , vol.31 , pp. 523-526
    • Gülmez, D.1    Woodford, N.2    Pelepou, M.3    Musthaq, S.4    Metan, G.5    Yakupogullari, Y.6
  • 51
    • 33750621549 scopus 로고    scopus 로고
    • Epidemiology of infections caused by extended-spectrum b-lactamase-producing Escherichia coli and Klebsiella spp.: A nested case control study from a tertiary hospital in London
    • Skippen I, Shemko M, Turton J, Kaufmann M, Palmer C, Shetty N. Epidemiology of infections caused by extended-spectrum b-lactamase-producing Escherichia coli and Klebsiella spp.: a nested case control study from a tertiary hospital in London. J Hosp Infect 2006;64:115-23.
    • (2006) J Hosp Infect , vol.64 , pp. 115-123
    • Skippen, I.1    Shemko, M.2    Turton, J.3    Kaufmann, M.4    Palmer, C.5    Shetty, N.6
  • 52
    • 34548260846 scopus 로고    scopus 로고
    • Prior use of carbapenems may be a significant risk factor for extended-spectrum b-lactamase-producing Escherichia coli or Klebsiella spp. in patients with bacteriemia
    • Martínez J, Aguilar J, Almela M, Marco F, Soriano A, López F et al. Prior use of carbapenems may be a significant risk factor for extended-spectrum b-lactamase-producing Escherichia coli or Klebsiella spp. in patients with bacteriemia. J Antimicrobiol Chemother 2006:1082-5.
    • (2006) J Antimicrobiol Chemother , pp. 1082-1085
    • Martínez, J.1    Aguilar, J.2    Almela, M.3    Marco, F.4    Soriano, A.5    López, F.6
  • 53
    • 31944432354 scopus 로고    scopus 로고
    • Bloodstream infections caused by extended-spectrumlactamase-producing Klebsiella pneumoniae: Risk factors, molecular epidemiology, and clinical outcome
    • Tumbarello M, Spanu T, Sanguinetti M, Citton R, Montuori E, Leone F et al. Bloodstream infections caused by extended-spectrumlactamase-producing Klebsiella pneumoniae: Risk Factors, Molecular Epidemiology, and Clinical Outcome. Antimicrob Agents Chemother 2006;50(2):498-504.
    • (2006) Antimicrob Agents Chemother , vol.50 , Issue.2 , pp. 498-504
    • Tumbarello, M.1    Spanu, T.2    Sanguinetti, M.3    Citton, R.4    Montuori, E.5    Leone, F.6
  • 55
    • 1842739446 scopus 로고    scopus 로고
    • Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients
    • Colodner R, Rock W, Chazan B, Keller N, Guy N, Sakran W et al. Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis 2004;23:163-7.
    • (2004) Eur J Clin Microbiol Infect Dis , vol.23 , pp. 163-167
    • Colodner, R.1    Rock, W.2    Chazan, B.3    Keller, N.4    Guy, N.5    Sakran, W.6
  • 56
    • 33644919433 scopus 로고    scopus 로고
    • Risk-factors for acquisition of extended-spectrum b-lactamaseproducing Escherichia coli among hospitalised patients
    • Peña C, Gudiol C, Tubau F, Saball M, Pujol M, Dominguez M et al. Risk-factors for acquisition of extended-spectrum b-lactamaseproducing Escherichia coli among hospitalised patients. Clin Microbiol Infect 2006;12:279-84.
    • (2006) Clin Microbiol Infect , vol.12 , pp. 279-284
    • Peña, C.1    Gudiol, C.2    Tubau, F.3    Saball, M.4    Pujol, M.5    Dominguez, M.6
  • 57
    • 67649556902 scopus 로고    scopus 로고
    • Choosing antibiotics for intra-abdominal infections: What do we mean by 〈high risk〉?
    • Swenson B, Metzger R, Hedrick T, McElearney S, Evans H, Smith R et al. Choosing Antibiotics for intra-abdominal infections: What Do We Mean by 〈High Risk〉? Surg Infect; 2009;10:1-11.
    • (2009) Surg Infect , vol.10 , pp. 1-11
    • Swenson, B.1    Metzger, R.2    Hedrick, T.3    McElearney, S.4    Evans, H.5    Smith, R.6
  • 58
    • 23744478434 scopus 로고    scopus 로고
    • Bowel colonization with resistant gram-negative bacilli after antimicrobial therapy of intra-abdominal infections: Observations from two randomized comparative clinical trials of ertapenem therapy
    • DiNubile M, Friendland I, Chan C, Motyl M, Giezel H, Shivaprakash M et al. Bowel colonization with resistant gram-negative bacilli after antimicrobial therapy of intra-abdominal infections: observations from two randomized comparative clinical trials of ertapenem therapy. Eur J Clin Microbiol Infect Dis 2005;24:443-9.
    • (2005) Eur J Clin Microbiol Infect Dis , vol.24 , pp. 443-449
    • Dinubile, M.1    Friendland, I.2    Chan, C.3    Motyl, M.4    Giezel, H.5    Shivaprakash, M.6
  • 59
    • 34548421063 scopus 로고    scopus 로고
    • Risk factors for colonization with extended-spectrum - Lactamase-producing bacteria and intensive care unit admission
    • Harris A, McGregor J, Johnson J, Strauss S, Moore A, Standiford H et al. Risk factors for colonization with extended-spectrum - lactamase-producing bacteria and intensive care unit admission. Emerg Infect Dis 2007;13:1144-9.
    • (2007) Emerg Infect Dis , vol.13 , pp. 1144-1149
    • Harris, A.1    McGregor, J.2    Johnson, J.3    Strauss, S.4    Moore, A.5    Standiford, H.6
  • 60
    • 12944295224 scopus 로고    scopus 로고
    • Boodstream infections caused by antibiotic-resistans Gram-negative bacilli: Risk factors and impact of inappropiate initial antimicrobial therapy on outcome
    • Kang C, Kim S, Park W, Lee K, Kim H, Kim E et al. Boodstream infections caused by antibiotic-resistans Gram-negative bacilli: risk factors and impact of inappropiate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 2005;49:760-6.
    • (2005) Antimicrob Agents Chemother , vol.49 , pp. 760-766
    • Kang, C.1    Kim, S.2    Park, W.3    Lee, K.4    Kim, H.5    Kim, E.6
  • 61
    • 0037390726 scopus 로고    scopus 로고
    • Impact of antibiotic-resistant Gram-negative bacilli infections on outcome in hospitalized patients
    • Raymond D, Pelletier S, Crabtree T, Evans H, Pruett T, Sawyer R. Impact of antibiotic-resistant Gram-negative bacilli infections on outcome in hospitalized patients. Crit Care Med 2003;31:1035-41.
    • (2003) Crit Care Med , vol.31 , pp. 1035-1041
    • Raymond, D.1    Pelletier, S.2    Crabtree, T.3    Evans, H.4    Pruett, T.5    Sawyer, R.6
  • 62
    • 0141792837 scopus 로고    scopus 로고
    • Treatment of secondary peritonitis: Is a less expensive broad -spectrum antibiotic as effective as a carbapenem?
    • Genné D, Menetrey A, Indino P, Sénéchaud C, Siegriest HH. Treatment of secondary peritonitis: Is a less expensive broad -spectrum antibiotic as effective as a carbapenem? Dig Surg 2003;20:415-20.
    • (2003) Dig Surg , vol.20 , pp. 415-420
    • Genné, D.1    Menetrey, A.2    Indino, P.3    Sénéchaud, C.4    Siegriest, H.H.5
  • 63
    • 0036797245 scopus 로고    scopus 로고
    • Evaluation of antimicrobial therapy management of 120 consecutive patients with secondary peritonitis
    • Sotto A, Lefrant J, Fabbro-Peray P, Muller L, Tafuri J, Navarro F et al. Evaluation of antimicrobial therapy management of 120 consecutive patients with secondary peritonitis. J Antimicrob Chemother 2002;50:569-76.
    • (2002) J Antimicrob Chemother , vol.50 , pp. 569-576
    • Sotto, A.1    Lefrant, J.2    Fabbro-Peray, P.3    Muller, L.4    Tafuri, J.5    Navarro, F.6
  • 65
    • 34347363002 scopus 로고    scopus 로고
    • Isolated bacteria and drug susceptibility associated with the course of surgical site infections
    • Kusachi S, Sumiyama Y, Arima Y, Yoshida Y, Tanaka H, Nakamura Y et al. Isolated bacteria and drug susceptibility associated with the course of surgical site infections. J Infect Chemother 2007;13:166-71.
    • (2007) J Infect Chemother , vol.13 , pp. 166-171
    • Kusachi, S.1    Sumiyama, Y.2    Arima, Y.3    Yoshida, Y.4    Tanaka, H.5    Nakamura, Y.6
  • 66
    • 23844486729 scopus 로고    scopus 로고
    • Tigecycline 301 and 306 Study G. the efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: Analysis of pooled clinical trial data
    • Babinchak T, Ellis-Grose E, Dartois N, Rose G, Loh E, Tigecycline 301 and 306 Study G. The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: Analysis of pooled clinical trial data. Clin Infect Dis 2005;41:S354-66.
    • (2005) Clin Infect Dis , vol.41
    • Babinchak, T.1    Ellis-Grose, E.2    Dartois, N.3    Rose, G.4    Loh, E.5
  • 67
    • 34250797913 scopus 로고    scopus 로고
    • The empiric treatment of nosocomial intra-abdominal infections
    • Dupont H. The empiric treatment of nosocomial intra-abdominal infections. Int J Infec Dis 2007;11(Supl. 1):1-6.
    • (2007) Int J Infec Dis , vol.11 , Issue.SUPPL. 1 , pp. 1-6
    • Dupont, H.1
  • 68
    • 0028856042 scopus 로고
    • Definition of the role of enterococcus in intraabdominal infction: Analysis of a prospective randomized trial
    • Burnett R, Haverstock D, Dellinger E, Reinhart H, Bohnen J, Rotstein O et al. Definition of the role of enterococcus in intraabdominal infction: Analysis of a prospective randomized trial. Surgery 1995;118:716-23.
    • (1995) Surgery , vol.118 , pp. 716-723
    • Burnett, R.1    Haverstock, D.2    Dellinger, E.3    Reinhart, H.4    Bohnen, J.5    Rotstein, O.6
  • 71
    • 0032407999 scopus 로고    scopus 로고
    • Third-generation cephalosporins and vancomycin as risk factors for postorpeative vancomycin-resistant enterococcus infection
    • Dahms R, Johnson E, Statz C, Lee J, Dunn D, Beilman G. Third-generation cephalosporins and vancomycin as risk factors for postorpeative vancomycin-resistant enterococcus infection. Arch Surg 1998;133:1343-6.
    • (1998) Arch Surg , vol.133 , pp. 1343-1346
    • Dahms, R.1    Johnson, E.2    Statz, C.3    Lee, J.4    Dunn, D.5    Beilman, G.6
  • 72
    • 0034212056 scopus 로고    scopus 로고
    • Coverage of enterococci in community acquired secondary peritonitis: Results of a randomized trial
    • Röhrborn A, Wacha H, Schöffel U, Billing A, Aeberhard P, Beghard B et al. Coverage of enterococci in community acquired secondary peritonitis: Results of a randomized trial. Surg Infect 2000;1:95-107.
    • (2000) Surg Infect , vol.1 , pp. 95-107
    • Röhrborn, A.1    Wacha, H.2    Schöffel, U.3    Billing, A.4    Aeberhard, P.5    Beghard, B.6
  • 73
    • 0037315316 scopus 로고    scopus 로고
    • Comparacion de ertapenem con piperacilina/tazobactam en el tratamiento de infecciones intraabdominales complicadas resultados de un ensayo comparativo aleatorizado doble ciego enfase III
    • Solomkin J, Yellin A, Rostein O, Christou N, Dellinger E, Tellado J et al. Comparacion de ertapenem con piperacilina/tazobactam en el tratamiento de infecciones intraabdominales complicadas resultados de un ensayo comparativo aleatorizado doble ciego enfase III. Ann Surg 2003;237:235-45.
    • (2003) Ann Surg , vol.237 , pp. 235-245
    • Solomkin, J.1    Yellin, A.2    Rostein, O.3    Christou, N.4    Dellinger, E.5    Tellado, J.6
  • 75
    • 34247177941 scopus 로고    scopus 로고
    • Randomized, multicenter, ddouble-blind study of efficacy, safety, and tolerability of intravenous ertapenem versus piperacillin/tazobactam in treatment of complicated intra-abdominal infections in hospitalized adults
    • Namias N, Solomkin J, Jensen E, Tomassini J, Abramson M. Randomized, multicenter, ddouble-blind study of efficacy, safety, and tolerability of intravenous ertapenem versus piperacillin/tazobactam in treatment of complicated intra-abdominal infections in hospitalized adults. Surg Infect 2007;8:15-28.
    • (2007) Surg Infect , vol.8 , pp. 15-28
    • Namias, N.1    Solomkin, J.2    Jensen, E.3    Tomassini, J.4    Abramson, M.5
  • 76
    • 0031467601 scopus 로고    scopus 로고
    • A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections. Cefepime Intra-abdominal Infection Study Group
    • Barie P, Vogel S, Dellinger E, Rostein O, Solomkin J, Yang J et al. A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections. Cefepime Intra-abdominal Infection Study Group. Arch Surg 1997;132:1294-302.
    • (1997) Arch Surg , vol.132 , pp. 1294-1302
    • Barie, P.1    Vogel, S.2    Dellinger, E.3    Rostein, O.4    Solomkin, J.5    Yang, J.6
  • 77
    • 33845693164 scopus 로고    scopus 로고
    • Ertapenem versus cefotetan prophylaxis in elective colorectal surgery
    • Itani K, Wilson S, Award S, Jensen E, Finn T, Abramson M. Ertapenem versus cefotetan prophylaxis in elective colorectal surgery. N Engl J Med 2006;355:2640-51.
    • (2006) N Engl J Med , vol.355 , pp. 2640-2651
    • Itani, K.1    Wilson, S.2    Award, S.3    Jensen, E.4    Finn, T.5    Abramson, M.6
  • 78
    • 77956468263 scopus 로고    scopus 로고
    • Conceptos de microbiologia aplicada
    • Guirao Garriga X (Ed.), Madrid: Aran
    • Mirelis Otero B, Prats Pastor G. Conceptos de microbiologia aplicada. En: Guirao Garriga X (Ed.). Infecciones Quirúrgicas. Madrid: Aran, 2006; p. 27-46.
    • (2006) Infecciones Quirúrgicas , pp. 27-46
    • Mirelis Otero, B.1    Prats Pastor, G.2
  • 79
    • 0033926236 scopus 로고    scopus 로고
    • In Vitro Activities of the glycylcycline GAR-936 against Gram-positive bacteria
    • Boucher H, Wennersten C, Eliopoulos G. In Vitro Activities of the glycylcycline GAR-936 against Gram-positive bacteria. Antimicrob Agents Chemother 2000;44:2225-9.
    • (2000) Antimicrob Agents Chemother , vol.44 , pp. 2225-2229
    • Boucher, H.1    Wennersten, C.2    Eliopoulos, G.3
  • 80
  • 81
    • 0029967489 scopus 로고    scopus 로고
    • Fungal Infections in surgical patients
    • Dean D, Buechard K. Fungal Infections in surgical patients. Am J Surg 1996;171:374-82.
    • (1996) Am J Surg , vol.171 , pp. 374-382
    • Dean, D.1    Buechard, K.2
  • 83
    • 0035723382 scopus 로고    scopus 로고
    • Yeast colonization in surgical patients with intra-abdominal perforations
    • Sandven P, Giercksky K, the NORGAS Group, and the Norweigian Yeast Study Group. Yeast colonization in surgical patients with intra-abdominal perforations. Eur J Clin Microbiol Infect Dis 2001;20:475-81.
    • (2001) Eur J Clin Microbiol Infect Dis , vol.20 , pp. 475-481
    • Sandven, P.1    Giercksky, K.2
  • 84
    • 33644587704 scopus 로고    scopus 로고
    • A bedside scoring system (〈Candida score〉) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization*
    • León C, Ruiz-Santana S, Saavedra P, Almirante B, Nolla-Salas J, Álvarez-Lerma F et al. A bedside scoring system («Candida score») for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization*. Crit Care Med 2006;34:730-7.
    • (2006) Crit Care Med , vol.34 , pp. 730-737
    • León, C.1    Ruiz-Santana, S.2    Saavedra, P.3    Almirante, B.4    Nolla-Salas, J.5    Álvarez-Lerma, F.6
  • 85
    • 7144226608 scopus 로고    scopus 로고
    • Epidemiology, diagnosis and treatment od systemic Candida infection in surgical patients under intensive care
    • Vincent J, Anaissie E, Bruining H, Demajo W, El-Ebiary M, Haber J et al. Epidemiology, diagnosis and treatment od systemic Candida infection in surgical patients under intensive care. Intensive Care Med 1998;24:206-16.
    • (1998) Intensive Care Med , vol.24 , pp. 206-216
    • Vincent, J.1    Anaissie, E.2    Bruining, H.3    Demajo, W.4    El-Ebiary, M.5    Haber, J.6
  • 86
    • 0032844229 scopus 로고    scopus 로고
    • Six years of surgical wound infection surveillance at a tertiary care center: Review of the microbiologic and epidemiological aspects of 20,007 wounds
    • Weiss III C, Statz C, Dahms R, Remucal M, Dunn D, GJ B. Six years of surgical wound infection surveillance at a tertiary care center: review of the microbiologic and epidemiological aspects of 20,007 wounds. Arch Surg 1999;134:1041-8.
    • (1999) Arch Surg , vol.134 , pp. 1041-1048
    • Weiss Iii, C.1    Statz, C.2    Dahms, R.3    Remucal, M.4    Dunn, D.5    Gj, B.6
  • 87
    • 0026100625 scopus 로고
    • Correlation of APACHE II score, drainage technique and outcome in postoperative intra-abdominal abscess
    • Levison M, Zeigler D. Correlation of APACHE II score, drainage technique and outcome in postoperative intra-abdominal abscess. Surg Gynecol Obstet 1991;172:89-94.
    • (1991) Surg Gynecol Obstet , vol.172 , pp. 89-94
    • Levison, M.1    Zeigler, D.2
  • 90
    • 11244347099 scopus 로고    scopus 로고
    • Effect of parenteral antibiotic administration on establishment of intestinal colonization by Candida glabrata in adult mice
    • Pultz N, Stiefel U, Ghannoum M, Helfand M, Dosnkey C. Effect of parenteral antibiotic administration on establishment of intestinal colonization by Candida glabrata in adult mice. Antimicrob Agents Chemother 2005;49(1):438-40.
    • (2005) Antimicrob Agents Chemother , vol.49 , Issue.1 , pp. 438-440
    • Pultz, N.1    Stiefel, U.2    Ghannoum, M.3    Helfand, M.4    Dosnkey, C.5
  • 91
    • 0027994336 scopus 로고
    • British Society for Antimicrobial Chemotherapy. Management of deep Candida infection in surgical and intensive care unit patients
    • British Society for Antimicrobial Chemotherapy. Management of deep Candida infection in surgical and intensive care unit patients. Intensive Care Med 1994;20:522-28.
    • (1994) Intensive Care Med , vol.20 , pp. 522-528
  • 93
    • 0033790317 scopus 로고    scopus 로고
    • Succesful treatment with liposomal amphoitercin B of an intraabdominal abscess due to Candida norvegensis associates with a gore-tex-mesh infection
    • Nolla-Salas J, Torres-Rodriguez J, Grau S, Isbert F, Torrella T, Riveiro M et al. Succesful Treatment with Liposomal Amphoitercin B of an Intraabdominal abscess Due to Candida norvegensis Associates with a Gore-Tex-Mesh Infection. Scand J Infect Dis 2000;32:560-2.
    • (2000) Scand J Infect Dis , vol.32 , pp. 560-562
    • Nolla-Salas, J.1    Torres-Rodriguez, J.2    Grau, S.3    Isbert, F.4    Torrella, T.5    Riveiro, M.6
  • 94
  • 95
    • 0141453241 scopus 로고    scopus 로고
    • Pseudomonasaeruginosa bacteremia: Risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome
    • Kang C, Kim S, Kim H, Park S, Choe Y, Oh M et al. Pseudomonasaeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin Infect Dis 2003;37:745-51.
    • (2003) Clin Infect Dis , vol.37 , pp. 745-751
    • Kang, C.1    Kim, S.2    Kim, H.3    Park, S.4    Choe, Y.5    Oh, M.6
  • 96
    • 0035089116 scopus 로고    scopus 로고
    • Prospective study of nosocomial colonization and infection dur to Pseudomonas aeruginosa in mechanically ventilated patients
    • Berthelot P, Grattard F, Mahul P, Jospé R, Venet C, Carricajo A et al. Prospective study of nosocomial colonization and infection dur to Pseudomonas aeruginosa in mechanically ventilated patients. Intensive Care Med 2001;27:503-12.
    • (2001) Intensive Care Med , vol.27 , pp. 503-512
    • Berthelot, P.1    Grattard, F.2    Mahul, P.3    Jospé, R.4    Venet, C.5    Carricajo, A.6
  • 97
    • 0027535975 scopus 로고
    • Surgical Infection Society Intra-abdominal Infection Study. Prospective evaluation of management techniques and outcome
    • Christou N, Barie P, Dellinger P, Waymack P, Stone H. Surgical Infection Society Intra-abdominal Infection Study. Prospective evaluation of management techniques and outcome. Arch Surg 1993;128:193-9.
    • (1993) Arch Surg , vol.128 , pp. 193-199
    • Christou, N.1    Barie, P.2    Dellinger, P.3    Waymack, P.4    Stone, H.5
  • 98
    • 0032930613 scopus 로고    scopus 로고
    • Risk factors associated with intraabdominal infections: A prospective multicenter study
    • Wacha H, Hau T, Dittmer R, Ohmann C, and the peritonitis study group. Risk factors associated with intraabdominal infections: a prospective multicenter study. Lagenbeck's Arch Surg 1999;384:24-32.
    • (1999) Lagenbeck's Arch Surg , vol.384 , pp. 24-32
    • Wacha, H.1    Hau, T.2    Dittmer, R.3    Ohmann, C.4
  • 99
    • 0030697183 scopus 로고    scopus 로고
    • Prognostic scoring systems to predict outcome in peritonitis and intra-abdominal sepsis
    • Bosscha K, Reijnders K, Hulstaert P, Algra A, van der Werken C. Prognostic scoring systems to predict outcome in peritonitis and intra-abdominal sepsis. Br J Surg 1997;84:1532-4.
    • (1997) Br J Surg , vol.84 , pp. 1532-1534
    • Bosscha, K.1    Reijnders, K.2    Hulstaert, P.3    Algra, A.4    Van Der Werken, C.5
  • 100
    • 0031695699 scopus 로고    scopus 로고
    • Epidemiology and pathophysiology of IAI
    • Farthmann E, Schöffel U. Epidemiology and pathophysiology of IAI. Infection 1998;26:329-34.
    • (1998) Infection , vol.26 , pp. 329-334
    • Farthmann, E.1    Schöffel, U.2
  • 101
    • 0037426726 scopus 로고    scopus 로고
    • The pathophysiology and treatment of sepsis
    • Hotchkiss R. The pathophysiology and treatment of sepsis. N Engl J Med 2003;348:138-50.
    • (2003) N Engl J Med , vol.348 , pp. 138-150
    • Hotchkiss, R.1
  • 102
    • 0036763320 scopus 로고    scopus 로고
    • The Surgical Infection Society Guidelines on Antimicrobial therapy for Intra-Abdominal Infections: An Executive Summary
    • Mazuski J, RG S, Nathens A, Dipiro J, Schein M, Kudsk K et al. The Surgical Infection Society Guidelines on Antimicrobial therapy for Intra-Abdominal Infections: An Executive Summary. Surgical Infections 2002;3:163-73.
    • (2002) Surgical Infections , vol.3 , pp. 163-173
    • Mazuski, J.1    Rg, S.2    Nathens, A.3    Dipiro, J.4    Schein, M.5    Kudsk, K.6
  • 104
    • 0020042126 scopus 로고
    • Implications of leukocytosis and fever at conclusion of antibiotic therapy for intraabdominal sepsis
    • Lennard E, Dellinger P, Wertz M, Minshew B. Implications of leukocytosis and fever at conclusion of antibiotic therapy for intraabdominal sepsis. Ann Surg 1982;195:19-24.
    • (1982) Ann Surg , vol.195 , pp. 19-24
    • Lennard, E.1    Dellinger, P.2    Wertz, M.3    Minshew, B.4
  • 105
    • 0035293941 scopus 로고    scopus 로고
    • Secondary peritonitis: Towards a definition of an optimal period of antibiotic treatment
    • Alcocer F, López E, Calva J, Herrera M. Secondary peritonitis: towards a definition of an optimal period of antibiotic treatment. Rev Invest Clin 2001;53:121-5.
    • (2001) Rev Invest Clin , vol.53 , pp. 121-125
    • Alcocer, F.1    López, E.2    Calva, J.3    Herrera, M.4
  • 106
    • 0028310797 scopus 로고
    • Minimal antibiotic therapy after emergency abdominal surgery: A prospective study
    • Shein M, Assalia A, Bachus H. Minimal antibiotic therapy after emergency abdominal surgery: a prospective study. Br J Surg 1994;81:989-91.
    • (1994) Br J Surg , vol.81 , pp. 989-991
    • Shein, M.1    Assalia, A.2    Bachus, H.3
  • 107
    • 38949101913 scopus 로고    scopus 로고
    • A prospective, double-blind, multicenter, randomized trial comparing ertapenem 3 vs. ≥ 5 days in community-acquired intraabdominal infection
    • Basoli A, Chirletti P, Cirino E, D'Ovidio N, Doglietto G, Giglio D et al. A prospective, double-blind, multicenter, randomized trial comparing ertapenem 3 vs. ≥ 5 days in community-acquired intraabdominal infection. J Gastrointest Surg 2008;12:592-600.
    • (2008) J Gastrointest Surg , vol.12 , pp. 592-600
    • Basoli, A.1    Chirletti, P.2    Cirino, E.3    D'Ovidio, N.4    Doglietto, G.5    Giglio, D.6
  • 108
    • 34547096478 scopus 로고    scopus 로고
    • C-Reactive protein-guided approach may shorten length of antimicrobial treatment of culture-proven late-onset sepsis. An intervention stud
    • Couto R, Barbosa J, Pedrosa T, Biscione F. C-Reactive protein-guided approach may shorten length of antimicrobial treatment of culture-proven late-onset sepsis. An intervention stud . Braz J Infect Dis 2007;11:240-5.
    • (2007) Braz J Infect Dis , vol.11 , pp. 240-245
    • Couto, R.1    Barbosa, J.2    Pedrosa, T.3    Biscione, F.4
  • 109
    • 0034592841 scopus 로고    scopus 로고
    • Modern surgical antibiotic prophylaxis and therapy: Less is more
    • Barie P. Modern surgical antibiotic prophylaxis and therapy: Less is more. Surg Infect 2000;1:23-9.
    • (2000) Surg Infect , vol.1 , pp. 23-29
    • Barie, P.1
  • 110
    • 0029591996 scopus 로고
    • A new model of intra-abdominal abscess. Usefulness for hydrosaline metabolism studies in parenteral nutrition associated with sepsis
    • Guirao X, Garcia-Domingo M, Llado L, Franch G, Oliva A, Muñoz A et al. A new model of intra-abdominal abscess. Usefulness for hydrosaline metabolism studies in parenteral nutrition associated with sepsis. J Surg Res 1995;59:658-65.
    • (1995) J Surg Res , vol.59 , pp. 658-665
    • Guirao, X.1    Garcia-Domingo, M.2    Llado, L.3    Franch, G.4    Oliva, A.5    Muñoz, A.6
  • 111
    • 62849095029 scopus 로고    scopus 로고
    • Phramacokinetic issues for antibiotics in the critically ill patient
    • Roberts J, Lipman J. Phramacokinetic issues for antibiotics in the critically ill patient. Crit Care Med 2009;37:840-51.
    • (2009) Crit Care Med , vol.37 , pp. 840-851
    • Roberts, J.1    Lipman, J.2
  • 112
    • 63149089185 scopus 로고    scopus 로고
    • Pharmakinetics of onec-daily dosing of ertapenem in critically ill patientes with severe sepsis
    • Brink A, Richards G, Schillack V, Kiem S, Schetag J. Pharmakinetics of onec-daily dosing of ertapenem in critically ill patientes with severe sepsis. Int J Antimicrob Agents 2009;33: 432-6.
    • (2009) Int J Antimicrob Agents , vol.33 , pp. 432-436
    • Brink, A.1    Richards, G.2    Schillack, V.3    Kiem, S.4    Schetag, J.5
  • 113
    • 33746816592 scopus 로고    scopus 로고
    • Tigecycline: First class glycylcycline a new choice for empiric therapy
    • Jones C, Petersen P. Tigecycline: First class glycylcycline a new choice for empiric therapy. Drug Discov Today 2006; 3:137-44.
    • (2006) Drug Discov Today , vol.3 , pp. 137-144
    • Jones, C.1    Petersen, P.2
  • 114
    • 29244453234 scopus 로고    scopus 로고
    • The role of vancomycin in the treatment paradigm
    • Stevens D. The role of vancomycin in the treatment paradigm. Clin Infect Dis 2006;42:S51-7.
    • (2006) Clin Infect Dis , vol.42
    • Stevens, D.1
  • 115
    • 34547539688 scopus 로고    scopus 로고
    • Empiric antimicrobial therapy in critical illness: Results of a Surgical Infection Society Survey
    • Aarts M, Granton J, Cook D, Bohnen J, Marshall J. Empiric antimicrobial therapy in critical illness: Results of a Surgical Infection Society Survey. Surg Infec 2007;8:329-36.
    • (2007) Surg Infec , vol.8 , pp. 329-336
    • Aarts, M.1    Granton, J.2    Cook, D.3    Bohnen, J.4    Marshall, J.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.